{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:55:18Z","timestamp":1767959718514,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08-DK120902"],"award-info":[{"award-number":["K08-DK120902"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2025.100773","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T23:31:11Z","timestamp":1756164671000},"page":"100773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance"],"prefix":"10.1016","volume":"5","author":[{"given":"Briana","family":"Macedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwesh","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Nephew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Serper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8608-3374","authenticated-orcid":false,"given":"Shazia Mehmood","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2025.100773_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GRF.0000000000000756","article-title":"Race-based versus race-conscious medicine in obstetrics and gynecology","volume":"66","author":"O'Brien","year":"2023","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.gastha.2025.100773_bib2","series-title":"Pediatric collections: social determinants of health (part 3: promoting health equity)","first-page":"5","article-title":"Eliminating race-based medicine","author":"Wright","year":"2022"},{"key":"10.1016\/j.gastha.2025.100773_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jacr.2023.03.017","article-title":"Understanding race-based medicine and its impact on radiology","volume":"20","author":"Medrano","year":"2023","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.gastha.2025.100773_bib4","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1377\/hlthaff.2023.00545","article-title":"Promoting equity in clinical decision making: dismantling race-based medicine","volume":"42","author":"Hernandez-Boussard","year":"2023","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.gastha.2025.100773_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMms2029562","article-title":"Race and genetic ancestry in medicine - a time for reckoning with racism","volume":"384","author":"Borrell","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2025.100773_bib6","first-page":"1013","article-title":"Race as proxy: situational racism and self-fulfilling stereotypes","volume":"53","author":"Wang","year":"2024","journal-title":"DePaul L Rev"},{"key":"10.1016\/j.gastha.2025.100773_bib7","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2025.100773_bib8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2025.100773_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.20517\/2394-5079.2018.49","article-title":"Screening for hepatocellular carcinoma: summary of current guidelines up to 2018","volume":"4","author":"Yilmaz","year":"2018","journal-title":"HR"},{"key":"10.1016\/j.gastha.2025.100773_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2025.100773_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3748\/wjg.v28.i6.665","article-title":"Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment","volume":"28","author":"Gokcen","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2025.100773_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2019.12.005","article-title":"Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B","volume":"72","author":"Yip","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2025.100773_bib13","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3390\/v14091968","article-title":"Evaluation of the hepatocellular carcinoma predictive scores PAGE-B and mPAGE-B among Brazilian patients with chronic hepatitis B virus infection","volume":"14","author":"Ferreira da Silva","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.gastha.2025.100773_bib14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/liv.14129","article-title":"External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy","volume":"39","author":"Lee","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.gastha.2025.100773_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jvh.12727","article-title":"Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: role of the PAGE-B score","volume":"24","author":"Brouwer","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastha.2025.100773_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","article-title":"Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy","volume":"69","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2025.100773_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/HEP.0000000000000528","article-title":"Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis","volume":"79","author":"Narasimman","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2025.100773_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31674","article-title":"Analysis of discrepancies between pulse oximetry and arterial oxygen saturation measurements by race and ethnicity and association with organ dysfunction and mortality","volume":"4","author":"Wong","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.gastha.2025.100773_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/CCM.0000000000005394","article-title":"Disparities in hypoxemia detection by pulse oximetry across self-identified racial groups and associations with clinical outcomes","volume":"50","author":"Henry","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.gastha.2025.100773_bib20","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.cgh.2020.12.029","article-title":"Racial and ethnic disparities in survival among patients with hepatocellular carcinoma in the United States: a systematic review and meta-analysis","volume":"20","author":"Rich","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2025.100773_bib21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.23.02745","article-title":"Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update","volume":"42","author":"Gordan","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gastha.2025.100773_bib22","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/cncr.30103","article-title":"Race\/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States","volume":"122","author":"Ha","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.gastha.2025.100773_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000349","article-title":"A randomized trial of mailed outreach with behavioral economic interventions to improve liver cancer surveillance","volume":"8","author":"Mehta","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastha.2025.100773_bib24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2016.10.042","article-title":"Mailed outreach program increases ultrasound screening of patients with cirrhosis for hepatocellular carcinoma","volume":"152","author":"Singal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2025.100773_bib25","first-page":"605","article-title":"Vertical transmission of hepatitis B virus: challenges and solutions","volume":"6","author":"Gentile","year":"2014","journal-title":"Int J Womens Health"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325001608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325001608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:14:55Z","timestamp":1767953695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572325001608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572325001608"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100773","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"100773"}}